Multivariate analysis further revealed that PANDAR expression was a significant independent predictor of poor survival in NSCLC patients (P=0.015), as well as histological classification (P=0.004) and TNM stage (P <0.001) (Table 1). Here, PANDAR is linked to non-small cell lung carcinoma.